Literature DB >> 3032396

Flow cytometric analysis of DNA in bone and soft-tissue tumors using nuclear suspensions.

J H Xiang, S S Spanier, N A Benson, R C Braylan.   

Abstract

Ninety-four bone and soft tissue tumors were analyzed for their DNA content using flow cytometry (FCM). A simple, rapid method for preparing isolated nuclear suspensions was used. Tissues, minced in a hypotonic solution containing detergent and propidium iodide as a fluorescent probe for DNA, provided in most instances high nuclear yields from only 0.02 to 0.03 g of solid tumor. Whereas all nonneoplastic samples had a diploid DNA content, various degrees of abnormal DNA distributions were detected in 90% of the neoplastic samples and were present in benign as well as malignant tumors. Our findings demonstrate that FCM DNA analysis is practical in most musculoskeletal tumors and support the observations of others that abnormal DNA content may serve as a general neoplastic marker in these tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032396     DOI: 10.1002/1097-0142(19870601)59:11<1951::aid-cncr2820591119>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.

Authors:  J H Xiang; A K Kimura
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

2.  Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.

Authors:  J V Bovée; M van Royen; A F Bardoel; C Rosenberg; C J Cornelisse; A M Cleton-Jansen; P C Hogendoorn
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management.

Authors:  Liesbeth Hameetman; Judith Vmg Bovée; Antonie Hm Taminiau; Herman M Kroon; Pancras Cw Hogendoorn
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

4.  Malignant transformation of osteoblastoma: study using image analysis microdensitometry.

Authors:  J Grace; S McCarthy; R Stankovic; W Marsden
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

5.  Telomere reduction in giant cell tumor of bone and with aging.

Authors:  H S Schwartz; G A Dahir; M G Butler
Journal:  Cancer Genet Cytogenet       Date:  1993-12

6.  Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours.

Authors:  D Charles Mangham; Nicholas A Athanasou
Journal:  Clin Sarcoma Res       Date:  2011-07-25

7.  Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability.

Authors:  Kim M Boerkamp; Gerard R Rutteman; Marja J L Kik; Jolle Kirpensteijn; Christoph Schulze; Guy C M Grinwis
Journal:  Cancers (Basel)       Date:  2012-12-03       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.